Microbiota-Associated Therapy for Non-Alcoholic Steatohepatitis-Induced Liver Cancer: A Review.
Microbiota-Associated Therapy for Non-Alcoholic Steatohepatitis-Induced Liver Cancer: A Review.
复制标题
DOI:
10.3390/ijms21175999
复制
发表时间:
2020-08-20
影响因子:
5.6
通讯作者:
Wu MS
中科院分区:
文献类型:
--
作者:
Chen YH;Wu WK;Wu MS
Even though advancement in medicine has contributed to the control of many diseases to date, cancer therapy continues to pose several challenges. Hepatocellular carcinoma (HCC) etiology is multifactorial. Recently, non-alcoholic fatty liver disease (NAFLD) has been considered as an important risk factor of HCC. NAFLD can be divided into non-alcoholic simple fatty liver (NAFL) and non-alcoholic steatohepatitis (NASH) based on histopathological features. Recently, studies have indicated that the gut microbiota is associated with NAFLD and HCC. Therefore, in this review, we have discussed the effects of gut microbiota-related mechanisms, including dysbiosis and gut barrier function, and gut microbiota-derived metabolites on NAFLD and HCC pathogenesis and the potential therapeutic strategies for NAFLD and HCC. With a better understanding of the gut microbiota composition and function, new and improved diagnostic, prognostic, and therapeutic strategies for common liver diseases can be developed.
登录
查看更多内容
影响因子:
3.7
作者:
Baker SS;Baker RD;Liu W;Nowak NJ;Zhu L
通讯作者:
Zhu L
DOI:
10.5005/jp-journals-10018-1226
发表时间:
2017-01
期刊:
Euroasian journal of hepato-gastroenterology
影响因子:
--
作者:
Abdel Monem SM
通讯作者:
Abdel Monem SM
影响因子:
64.8
作者:
Devkota, Suzanne;Wang, Yunwei;Musch, Mark W.;Leone, Vanessa;Fehlner-Peach, Hannah;Nadimpalli, Anuradha;Antonopoulos, Dionysios A.;Jabri, Bana;Chang, Eugene B.
通讯作者:
Chang, Eugene B.
影响因子:
4.8
作者:
Brown, AJ;Goldsworthy, SM;Dowell, SJ
通讯作者:
Dowell, SJ
影响因子:
13.5
作者:
Bajaj, Jasmohan S.;Kakiyama, Genta;Gillevet, Patrick M.
通讯作者:
Gillevet, Patrick M.